Generic EpiPen drug could actually make more money for Mylan
August 29, 2016 at 12:09 PM EDT
Some are questioning whether Mylan's generic EpiPen may net the drugmaker more revenue than the original version.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.